Oncology PracticeTivozanib gets EU approval for advanced RCCAugust 30, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeFDA advisory committee to consider adjuvant sunitinib for RCCAugust 16, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeSequential pazopanib and everolimus nets good survival in metastatic RCCAugust 8, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeAbiraterone plus ADT boosts prostate cancer survivalJuly 26, 2017Genitourinary Cancer
Oncology PracticeNo survival benefit with adjuvant girentuximab in high-risk RCCJuly 19, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeSavolitinib improves PFS in some with MET-driven papillary renal cell carcinomaJuly 6, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticePROTECT: Pazopanib falls short as adjuvant therapy for high-risk RCCJune 19, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeHypogonadism after testicular cancer treatment can have lifelong impactJune 14, 2017Genitourinary CancerPatient & Survivor Care
Oncology PracticeADT+RT duration can safely be shortened in high risk PCJune 12, 2017Genitourinary Cancer
Oncology PracticeVIDEO: Survival improves when cancer patients self-report symptomsJune 5, 2017Breast CancerGenitourinary CancerGynecologic CancerLung CancerPatient & Survivor Care
Oncology PracticeImmune-agonist combo has activity against several tumor typesJune 5, 2017Immuno-oncologyImmunotherapyBreast CancerMelanomaRenal Cell CarcinomaGynecologic CancerGenitourinary Cancer
Oncology PracticeTest goes wide and deep to detect free tumor DNA in bloodJune 4, 2017Lung CancerBreast CancerGenitourinary CancerPatient & Survivor CarePractice ManagementBusiness of Medicine
Oncology PracticeVIDEO: Abiraterone improves survival in high-risk prostate cancerJune 4, 2017Genitourinary Cancer
Oncology PracticeVIDEO: Low testosterone common after testicular cancerJune 3, 2017Genitourinary Cancer
Oncology PracticeFDA approves pembrolizumab for advanced urothelial carcinomaMay 18, 2017Genitourinary CancerImmuno-oncology
